Hence, the infiltration of Th1 CD4 + T cells and CD68 + macrophages in tissues is the key to affecting the efficacy of neoadjuvant chemotherapy and prognosis in osteosarcoma patients. This evidence concerns the gene CD68 and osteosarcoma.